Lymphoproliferative disorders in an IL-7 transgenic mouse line.
A high incidence of severe lymphoproliferative disease was observed in a newly generated strain of mice carrying murine IL-7 as a transgene under the control of the E alpha (MHC class II) promoter. An analysis of the cells from lesions in these mice shows the selective expansion of cells at an early stage of B cell development and, more interestingly, expansion of cells phenotypically identical to the recently reported bipotent (B/macrophage) stem cell populations described in midgestation embryonic liver. Such cells can be propagated (and remain dependent upon) bone marrow feeder cell lines obtained from IL-7 transgenic mice. A molecular analysis of fresh and cultured cells reveals that the lesions are oligoclonal, or in rare cases monoclonal, and include clones of cells with unrearranged Ig heavy chain loci. These data suggest that IL-7 acts at multiple stages of B cell development. Furthermore cell lines derived from IL-7 transgenic mice may provide a novel source of rare factor-dependent bipotent stem cells.
Fisher
A G
AG
Laboratoire de Génétique Moléculaire des Eucaryotes, Institut de Chimie Biologique, Strasbourg, France.
Burdet
C
C
LeMeur
M
M
Haasner
D
D
Gerber
P
P
Ceredig
R
R
D000818:Animals; D001402:B-Lymphocytes / Q000473:pathology; D002454:Cell Differentiation; D015326:Gene Rearrangement, B-Lymphocyte, Heavy Chain / Q000235:genetics*; D015851:Interleukin-7 / Q000235:genetics* / Q000378:metabolism; D008232:Lymphoproliferative Disorders / Q000235:genetics*; D051379:Mice; D008822:Mice, Transgenic / Q000235:genetics*; D016133:Polymerase Chain Reaction; D014162:Transfection
D015851:Interleukin-7